LMR Master Fund’s Assembly Biosciences ASMB Stock Holding History

LMR Master Fund’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-524	Closed	-$75K	–	307
2013 Q2	$75K	Buy	+524	New	+$82.1K	0.01%	430

Other funds holding ASMB

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LMR Master Fund's ASMB Position: Q3 2013 in Review

LMR Master Fund sold out of Assembly Biosciences (ASMB) in Q3 2013, closing a stake of 524 shares — an estimated $75K sold.

LMR Master Fund first reported a position in ASMB in Q2 2013 and held it in 1 quarter. The position peaked at $75K in Q2 2013. 37 funds tracked by Wall St. Rank hold ASMB as of Q3 2013.

LMR Master Fund reported no remaining Assembly Biosciences position as of Q3 2013 after selling out during the quarter.
LMR Master Fund sold 524 Assembly Biosciences shares in Q3 2013, an estimated $75K.
LMR Master Fund first reported a position in Assembly Biosciences in Q2 2013 and held it in 1 quarter.
LMR Master Fund's Assembly Biosciences position peaked at $75K in Q2 2013.
37 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2013.

Based on LMR Master Fund's 13F filing for Q3 2013, filed 14 Nov 2013.